 - This study population will consist of patients with a prior diagnosis of celiac disease based on intestinal biopsy Marsh score of 1-4 who report control of symptoms with adherence to gluten free dietGFD for at least one year and have a baseline IgA antibody to tissue transglutaminaseIgA-tTG within the normal range. 